Written by Klarity Editorial Team
Published: May 11, 2026

If you’re a psychiatrist or psychiatric mental health nurse practitioner treating anxiety disorders via telehealth, you’re navigating one of the most complex regulatory landscapes in healthcare right now. Between shifting federal DEA rules and state-specific prescribing laws, it’s easy to feel like you need a law degree just to write a Xanax prescription over video.
Here’s what you actually need to know to stay compliant while serving your anxiety patients remotely.
Let’s start with the big one: Can you prescribe benzodiazepines via telehealth without ever seeing the patient in person?
As of 2026, the answer is yes — but with a massive asterisk.
Under normal circumstances, the federal Ryan Haight Act requires an in-person medical evaluation before prescribing any controlled substance ‘by means of the Internet.’ That includes common anxiety medications like alprazolam (Xanax), lorazepam (Ativan), and clonazepam (Klonopin) — all Schedule IV controlled substances.
But we’re not operating under normal circumstances. In November 2024, the DEA announced its third extension of COVID-era telehealth flexibilities through December 31, 2025. This means you can initiate controlled substance prescriptions for anxiety entirely via telehealth — no in-person visit required — as long as you:
Nobody knows for certain. In 2023, the DEA proposed new rules that would have reinstated in-person visit requirements (allowing only a 30-day supply via telehealth before requiring face-to-face evaluation). That proposal generated over 38,000 public comments — mostly negative — and the DEA backed off to develop a ‘new path forward for telemedicine.’
Bottom line: The current flexibility allows fully remote anxiety treatment with controlled medications, but you should prepare contingency plans. Some providers are already establishing relationships with local clinics for potential in-person exams if requirements change. Others are exploring whether the DEA’s promised ‘special telemedicine registration’ (still not implemented as of 2026) might provide a permanent solution.
Federal law sets the floor, but states add layers of requirements that vary wildly. Here’s what matters for the six largest telehealth markets:
The good news: California doesn’t require an in-person exam before prescribing via telehealth. As long as your telehealth evaluation meets the standard of care (which can include asynchronous elements like questionnaires), you’re compliant with state law.
The requirements:
For PMHNPs: California is transitioning to full practice authority under AB 890. By January 2026, experienced NPs (3+ years) can practice independently across all settings. Until then, you need physician oversight via standardized procedures.
Texas mandates synchronous audio-visual interaction for new patient telehealth visits. No establishing care via phone alone.
Key restrictions:
The practical impact: A Texas PMHNP treating comorbid ADHD and anxiety cannot prescribe stimulants (Schedule II) via telehealth. You’d need a collaborating psychiatrist for that prescription. But benzodiazepines (Schedule IV) are fair game under your prescriptive authority agreement.
Florida explicitly bans telehealth prescribing of Schedule II controlled substances — except for four scenarios, including treatment of psychiatric disorders. This means psychiatrists and psychiatric NPs can prescribe stimulants or other Schedule II psychotropics via telehealth for mental health conditions, but the same provider couldn’t prescribe opioids for pain remotely.
Additional Florida requirements:
For PMHNPs: Florida requires physician supervision protocols. The state’s 2020 NP independence law excluded psychiatric specialists — only primary care NPs qualified. You also face a 7-day limit on Schedule II prescriptions unless you’re certified as a ‘psychiatric nurse’ treating mental illness (which most PMHNPs are).
New York allows telehealth prescribing without state-level restrictions beyond federal law, but the I-STOP prescription monitoring requirements are strict.
What you must do:
The PMP requirement isn’t optional. State boards audit for compliance, and failure to check can trigger disciplinary action even if you did nothing else wrong.
Pennsylvania doesn’t have comprehensive telehealth prescribing statutes, but the state’s opioid crisis response laws created specific requirements for benzodiazepines and opioids.
Key requirements:
Pennsylvania hasn’t granted NP independence yet, despite multiple legislative attempts. You’ll need a collaborating physician agreement that explicitly authorizes controlled substance prescribing.
Illinois offers Full Practice Authority for APRNs who complete 4,000 hours of clinical experience and additional training. Once granted, you can practice independently — including prescribing controlled substances — with one caveat: during your first 5 years of FPA, you must have a physician available for consultation when prescribing Schedule II opioids (not applicable to stimulants or non-narcotic Schedule II drugs).
Other Illinois requirements:
Here’s the part most articles skip: acquiring psychiatric patients through traditional marketing is expensive and unpredictable.
If you’re thinking ‘I’ll just build my own telehealth practice and do my own marketing,’ understand what you’re signing up for:
Most solo providers don’t have $3,000-5,000/month to gamble on marketing channels with uncertain ROI.
This is where platforms like Klarity Health shift the economics entirely. Instead of paying upfront for marketing that might not work, you pay a standard listing fee only when a pre-qualified patient books with you. You’re not paying for clicks that don’t convert or monthly subscriptions while you build volume. You’re paying for actual appointments with patients already matched to your specialty and availability.
What you get:
What you avoid:
For most prescribers — especially those starting out or scaling — paying per appointment removes all the financial risk of patient acquisition. You’re guaranteed positive ROI because you only pay when you earn.
Regardless of your state, make sure you have:
Treating anxiety via telehealth in 2026 means operating under temporary federal flexibility that could change, while navigating permanent state-level requirements that vary dramatically by jurisdiction.
If you’re a psychiatrist: You have the broadest scope and fewest restrictions. Your main challenges are multi-state licensing and staying on top of PDMP requirements in each state.
If you’re a PMHNP: Your scope depends entirely on which state your patient is located in. Full independence in New York and Illinois, physician oversight required in Texas, Florida, and Pennsylvania. Schedule II restrictions in multiple states mean you need backup for certain prescriptions.
For both: The regulatory complexity is real, but so is the demand. Anxiety is the most common mental health condition in America, and millions of patients prefer remote treatment. Platforms that handle the infrastructure, patient matching, and compliance frameworks let you focus on what you do best — treating patients — instead of becoming an expert in healthcare law and digital marketing.
The telehealth opportunity in psychiatry isn’t going away. The providers who succeed will be those who understand the regulations, build compliant workflows, and partner with platforms that solve the patient acquisition challenge without the marketing gamble.
Can I prescribe benzodiazepines via telehealth without ever seeing the patient in person?
Yes, as of 2026, under extended federal DEA rules through December 31, 2025. You must conduct an appropriate evaluation via live video and comply with all state requirements. This flexibility may change after 2025 when DEA finalizes new telemedicine rules.
Do I need a separate license to practice telehealth?
Most states require a full medical/nursing license for the state where the patient is located. Florida offers a Telehealth Provider Registration for out-of-state clinicians. Some physicians can use the Interstate Medical Licensure Compact to expedite multi-state licensing.
What’s the difference between psychiatrist and PMHNP scope for anxiety treatment?
Psychiatrists have full independent practice authority in all states with no prescribing restrictions. PMHNPs face state-varying requirements: some states grant full independence (NY, IL for experienced NPs), while others require physician collaboration (TX, FL, PA). Some states restrict NP prescribing of Schedule II substances.
How often do I need to check the prescription monitoring program?
It varies by state. New York requires checking before every Schedule II-IV prescription (including each benzodiazepine refill). Pennsylvania requires checks before initial prescriptions and each subsequent refill of benzos or opioids. California requires at least every 4 months. Texas mandates checking before prescribing benzos, opioids, barbiturates, or carisoprodol.
Can PMHNPs prescribe stimulants for comorbid ADHD and anxiety?
Depends on the state. Texas prohibits APRNs from prescribing Schedule II in outpatient settings entirely. Florida limits Schedule II prescriptions to 7 days unless you’re a certified psychiatric nurse treating mental illness. States with full NP practice authority (like independent-practicing NPs in NY or IL) allow Schedule II prescribing under their scope.
What happens if DEA rules change in 2026?
The DEA is expected to finalize new telemedicine prescribing rules sometime after the current extension expires December 31, 2025. Proposed 2023 rules would have required in-person visits with limited telehealth exceptions. Providers should prepare contingency plans like establishing relationships with local clinics for in-person exams if needed.
Is audio-only telehealth acceptable for prescribing anxiety medications?
Generally not recommended for controlled substances. Most states and DEA guidance expect live audio-video for establishing new patient relationships and prescribing controlled substances. Illinois explicitly allows audio-only for mental health services if video isn’t available, but federal rules may constrain this for new controlled prescriptions.
Do I need malpractice insurance that specifically covers telehealth?
Yes. Many traditional malpractice policies exclude or limit telehealth coverage. Ensure your policy explicitly covers telehealth practice in all states where you’re licensed to practice.
DEA and HHS Extend Telemedicine Flexibilities Through 2025 – U.S. Drug Enforcement Administration, November 15, 2024. Official announcement of third extension of COVID-era telehealth prescribing rules for controlled substances through December 31, 2025. www.dea.gov
State Telehealth Policies: Online Prescribing – Center for Connected Health Policy, updated January 9, 2026. Comprehensive state-by-state analysis of telehealth prescribing laws with official statute citations. www.cchpca.org/topic/online-prescribing/
Ryan Haight Online Pharmacy Consumer Protection Act of 2008 – 21 U.S.C. § 829(e) and § 802(54). Federal law requiring in-person medical evaluation before prescribing controlled substances via the Internet, with telemedicine exceptions. www.cchpca.org
Florida Statutes Section 456.47: Telehealth – Florida Legislature, 2025 edition. State law establishing telehealth requirements including controlled substance prescribing restrictions and psychiatric disorder exception. www.flsenate.gov
New York I-STOP Prescription Monitoring Program Requirements – New York State Department of Health, effective August 27, 2013 (accessed 2025). Mandates prescribers check PMP registry before every Schedule II-IV prescription. healthweb-back.health.ny.gov
Find the right provider for your needs — select your state to find expert care near you.